Clinical Trial Update: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2, Phase 3]

View source ↗

Summary

Extension study update for Treprostinil Palmitil Inhalation Powder (TPIP) in pulmonary hypertension associated with interstitial lung disease (PH-ILD); the Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil Palmitil Inhalation Powder (TPIP) (treprostinil palmitil inhalation powder)

Snippet

Sponsor: Insmed Incorporated | Conditions: Pulmonary Hypertension, Interstitial Lung Disease | Phase 2, Phase 3 | Status: COMPLETED